Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

CADL US Equity

Candel Therapeutics, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1841387 · FY ends Dec 31
$13.50
+1.45 (+12.03%)
USD · as of 2026-08-19 · marketstack
1 8-K filing · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-138-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-2713GSchedule 13G filed — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-27

Every row is a filed document, checked against its EDGAR index.